FMO5 and aortic aneurysm: In Fbn1C1039G/+ mice, ROS inhibition with apocynin (an unspecific NADPH oxidase inhibitor) attenuated aortic aneurysm progression and AngII-dependent enhanced ROS production in a TGF-β-dependent manner [223].